Suberoyl bis-hydroxamic Acid CAS: 38937-66-5
MF: C8H16N2O4
MW: 204.22
Inhibits histone deacetylation.

Suberoyl bis-hydroxamic Acid (CAS 38937-66-5)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 117ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
5
1
4
0
3
0
2
0
1
0
Synonyme: suberic bishydroxamate
Application: Inhibits histone deacetylation
Numéro CAS: 38937-66-5
Pureté: ≥98%
Masse Moléculaire: 204.22
Formule Moléculaire: C8H16N2O4
* Consulter le Certificat d'Analyses pour les données spécifiques à un lot (incluant la teneur en eau).
Postez un avis sur ce produit et recevez 15 CruzCredits

Suberoyl bis-hydroxamic Acid, an HDAC (histone deacetylase) inhibitor, inhibits HDAC1 (ID50 = 0.25 μM) and HDAC3 (ID50 = 0.3 μM). Suberoyl bis-hydroxamic Acid has been shown to induce differentiation of certain murine cells via blocking of HEXIM1 (hexamethylene bisacetamide) activity. Other experiments have shown Suberoyl bis-hydroxamic Acid to induce apoptosis in proliferative cells via induction of P21, P53, PUMA, and Bax gene expression. Additionally, the compound has been noted to activate Notch 1 signaling, which is associated with antiproliferative and apoptotic effects in certain medullary cells. Additional proteins induced by Suberoyl bis-hydroxamic Acid include caspase-3, poly ADP-ribose polymerase, Bcl-X(L), and Bad whose effects range from cellular growth, senescence and apoptosis.


Références

1. Preston, C.M. and McFarlane, M. 1998. Virology. 249: 418-426. PMID: 9791032
2. Zhuang, Z.G., et al. 2008. Acta Pharmacol. Sin. 29: 1459-1466. PMID: 19026165
3. Ning, L., et al. 2008. Oncologist. 13: 98-104. PMID: 18305053
4. Flis, S., et al. 2009. Biochem. Biophys. Res. Commun. 387: 336-341. PMID: 19596269

État Physique :
Solid
Solubilité :
Soluble in DMSO (~1.3 mg/ml), DMF (~0.1 mg/ml), and a 1:10 solution of DMSO:PBS(pH7.2) (~0.1 mg/ml).
STOCKAGE :
Store at room temperature
Point de fusion :
153-155° C (lit.)
Point d'Ébullition :
491.62° C (Predicted)
Densité :
1.22 g/cm3
Indice de Réfraction :
n20D 1.50
IC50 :
HDAC1: IC50 = 0.25 µM; HDAC3: IC50 = 0.30 µM; the growth of proliferating keratinocytes : IC50 = 11.57 µM; the growth of squamous cell carcinoma cells: IC50 = 5.39 µM; HT-29 (Colon adenocarcinoma cells): EC5050 = 32000 nM (Homo sapiens); SK-BR-3 (Breast adenocarcinoma): EC5050 = 27000 nM (Homo sapiens); Plasmodium falciparum: IC50 = 1530 nM (Plasmodium falciparum); Histone deacetylase HD2: IC50 = 320 nM (Zea mays); Histone deacetylase 2: IC50 = 1150 nM (Rattus norvegicus)
Ki Data :
Histone deacetylase 3: Ki= 125 nM (Homo sapiens); Histone deacetylase 5: Ki= 9500 nM (Homo sapiens); Histone deacetylase 6: Ki= 14.5 nM (Homo sapiens); Histone deacetylase 2: Ki= 29 nM (Homo sapiens); Histone deacetylase 8: Ki= 950 nM (Homo sapiens); Histone deacetylase 1: Ki= 19 nM (Homo sapiens)
Valeurs pK :
pKa: 9.18
Pour la Recherche Uniquement. Non conforme pour le Diagnostic ou pour une Utilisation Thérapeutique.
WGK Allemagne :
3
PubChem CID :
5173
Numéro MDL :
MFCD00192455
SMILES :
C(CCCC(=O)NO)CCC(=O)NO

Télécharger la Fiche de Sécurité/ SDS (MSDS)

CERTIFICAT D'ANALYSE

Pour une bonne lecture, Adobe Acrobat Reader est requis,
imprimer et commenter les documents PDF

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 166ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 9ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. est leader mondial dans le développement de produits pour la recherche biomédicale. Contactez-nous au 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. Tous Droits Réservés. "Santa Cruz Biotechnology", et le logo Santa Cruz Biotechnology, Inc., "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", le logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", et "EZ Touch" sont des marques déposées de Santa Cruz Biotechnology, Inc.
Toutes les marques sont la propriété de leurs propriétaires respectifs.